A $435 Million Bet on ‘Reversing Aging’

Date:

Share post:



Biotech startup NewLimit secures a major funding round after claiming a ‘breakthrough discovery’ of a prototype medicine that rewinds cellular aging in the liver.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

If We’re in an AI Bubble, History Says This Is the Best Way to Recession-Proof Your Portfolio

The stock market has had a pretty good year so far in 2026. The S&P 500 index...

🔥Invest in REITs using your Mobile Phone! 🔥

Watch Related Video Here: REITs Investing From Your Phone! (My firstmetro sec review, account opening, and tutorial) Subscribe here:...

Chipotle Offering BOGO Entrées Today for Back-to-School Season

Chipotle BOGO Entrées Today for School Spirit Promotion Chipotle is celebrating the back-to-school season with a School Spirit...